BS
PFE icon

Boenning & Scattergood’s Pfizer PFE Stock Holding History

Boenning & Scattergood’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$7.01M Sell
135,405
-3,405
-2% -$163K 1.13% 9
2022
Q3 		$6.07M Buy
138,810
+9,565
+7% +$465K 1.24% 11
2022
Q2 		$6.78M Sell
129,245
-6,160
-5% -$314K 1.28% 9
2022
Q1 		$7.01M Buy
135,405
+4,532
+3% +$235K 1.13% 9
2021
Q4 		$7.73M Buy
130,873
+7,954
+6% +$394K 1.24% 11
2021
Q3 		$5.29M Buy
122,919
+4,385
+4% +$194K 0.93% 21
2021
Q2 		$4.64M Sell
118,534
-3,412
-3% -$133K 0.81% 25
2021
Q1 		$4.42M Buy
121,946
+34,096
+39% +$1.21M 0.84% 23
2020
Q4 		$3.23M Sell
87,850
-12,195
-12% -$447K 0.68% 35
2020
Q3 		$3.48M Buy
100,045
+11,887
+13% +$417K 0.84% 26
2020
Q2 		$2.73M Buy
88,158
+1,839
+2% +$62.5K 0.73% 31
2020
Q1 		$2.67M Sell
86,319
-1,217
-1% -$41.5K 0.92% 24
2019
Q4 		$3.25M Buy
87,536
+4,678
+6% +$167K 0.84% 28
2019
Q3 		$2.83M Sell
82,858
-1,660
-2% -$60.4K 0.82% 30
2019
Q2 		$3.47M Buy
84,518
+1,156
+1% +$45.9K 1.02% 21
2019
Q1 		$3.36M Sell
83,362
-1,998
-2% -$80K 1.01% 20
2018
Q4 		$3.54M Buy
85,360
+78
+0.1% +$3.24K 1.23% 16
2018
Q3 		$3.57M Buy
85,282
+487
+0.6% +$18.7K 1.13% 16
2018
Q2 		$2.92M Buy
+84,795
New +$2.9M 0.96% 20

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boenning & Scattergood's PFE Position: Q4 2022 in Review

Boenning & Scattergood reduced its Pfizer (PFE) stake by 2.5% in Q4 2022, selling an estimated $163K and leaving 135,405 shares worth $7.01M. The position accounts for 1.13% of the portfolio, ranked #9.

Boenning & Scattergood first reported a position in PFE in Q2 2018 and has held it in 19 quarters since. The position peaked at $7.73M in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Boenning & Scattergood held 135,405 shares of Pfizer worth $7.01M as of Q4 2022.
  • Boenning & Scattergood sold 3,405 Pfizer shares in Q4 2022, an estimated $163K.
  • Pfizer made up 1.13% of Boenning & Scattergood's portfolio in Q4 2022, its #9 holding.
  • Boenning & Scattergood first reported a position in Pfizer in Q2 2018 and has held it in 19 quarters since.
  • Boenning & Scattergood's Pfizer position peaked at $7.73M in Q4 2021.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.